Admera Health, LLC, a leading provider of Next-Generation Sequencing services for researchers worldwide, today announced it has received re-accreditation from The Accreditation Committee of the College of American Pathologists (CAP).
For the full article click here: Admera Health Achieves CAP Re-Accreditation, Solidifying Its Position as a Leader in Next-Generation Sequencing and Biopharma Solutions